Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec Looks To Next-Generation LVADs To Revive Sinking Sales

This article was originally published in The Gray Sheet

Executive Summary

Thoratec reported a near 10 percent year-over-year decline in revenue in the second quarter; physicians have become more selective about which patients to implant with a HeartMate II ventricular assist device, the firm says. The company is looking to next-generation of HeartMate products as well as the technology it acquired in the Apica deal to help it return to growth.

Advertisement

Related Content

VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec
VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec
Thoratec Set To Begin U.S. Trial Of Catheter Heart Pump To Assist PCI
Thoratec On Track For Late 2015 HeartMate III Launch
Thoratec Seeks 'Cultural Revolution' As Rival HeartWare Makes Strides
Thoratec Goes Back To The Future With CEO Appointment
Thoratec Seeks Less Invasive VAD Access With Apica Acquisition
Pressure Builds In Ventricular Assist Market
Thoretec Pipeline: HeartMate III Fully Magnetic LVAD Trial Set For 2012

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT033232

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel